carmustine has been researched along with Ache in 7 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The median VAS scores of all patients were above 4 (moderate to severe pain) before the administration of transdermal fentanyl." | 7.74 | [Transdermal fentanyl in treating severe painful mucositis caused by autologous hematopoietic stem cell transplantation]. ( Bu, Q; Cai, QQ; Gao, Y; Huang, HQ; Lin, XB; Peng, YL; Wang, BF, 2007) |
| "33 patients with advanced refractory multiple myeloma received a combination of vincristine, cyclophosphamide, carmustine, melphalan and steroids (M-2 protocol)." | 7.67 | M-2 protocol for melphalan-resistant and relapsing multiple myeloma. ( Cavo, M; Galieni, P; Gobbi, M; Tassi, C; Tura, S, 1988) |
| " The median VAS scores of all patients were above 4 (moderate to severe pain) before the administration of transdermal fentanyl." | 3.74 | [Transdermal fentanyl in treating severe painful mucositis caused by autologous hematopoietic stem cell transplantation]. ( Bu, Q; Cai, QQ; Gao, Y; Huang, HQ; Lin, XB; Peng, YL; Wang, BF, 2007) |
| "33 patients with advanced refractory multiple myeloma received a combination of vincristine, cyclophosphamide, carmustine, melphalan and steroids (M-2 protocol)." | 3.67 | M-2 protocol for melphalan-resistant and relapsing multiple myeloma. ( Cavo, M; Galieni, P; Gobbi, M; Tassi, C; Tura, S, 1988) |
| "Seventy-nine patients harboring recurrent brain tumors received four cycles of infraophthalmic carotid injections of 160 mg of carmustine." | 2.67 | Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumors. ( Hager, B; Hannisdal, E; Hirschberg, H; Nome, O; Watne, K, 1992) |
| "High-grade primary and refractory brain tumors and metastases to the brain from other primary sites are associated with a grave prognosis." | 1.27 | Phase I trial of thermochemotherapy for brain malignancy. ( Benz, ML; Drury, B; Morton, DL; Rand, RW; Silberman, AW; Storm, FK, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, HQ | 1 |
| Cai, QQ | 1 |
| Lin, XB | 1 |
| Wang, BF | 1 |
| Bu, Q | 1 |
| Gao, Y | 1 |
| Peng, YL | 1 |
| Yamada, K | 1 |
| Bremer, AM | 1 |
| West, CR | 1 |
| Ghoorah, J | 1 |
| Park, HC | 1 |
| Takita, H | 1 |
| Watne, K | 1 |
| Hannisdal, E | 1 |
| Nome, O | 1 |
| Hager, B | 1 |
| Hirschberg, H | 1 |
| Spitzer, G | 1 |
| Deisseroth, A | 1 |
| Ventura, G | 1 |
| Jagannath, S | 1 |
| Fogel, B | 1 |
| Taylor, K | 1 |
| Huan, S | 1 |
| Dunphy, F | 1 |
| Dicke, K | 1 |
| Souza, L | 1 |
| Mrozek-Orlowski, M | 1 |
| Christie, J | 1 |
| Flamme, C | 1 |
| Novak, J | 1 |
| Cavo, M | 1 |
| Galieni, P | 1 |
| Tassi, C | 1 |
| Gobbi, M | 1 |
| Tura, S | 1 |
| Silberman, AW | 1 |
| Rand, RW | 1 |
| Storm, FK | 1 |
| Drury, B | 1 |
| Benz, ML | 1 |
| Morton, DL | 1 |
1 trial available for carmustine and Ache
| Article | Year |
|---|---|
Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumors.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma | 1992 |
6 other studies available for carmustine and Ache
| Article | Year |
|---|---|
[Transdermal fentanyl in treating severe painful mucositis caused by autologous hematopoietic stem cell transplantation].
Topics: Administration, Cutaneous; Adolescent; Adult; Analgesics, Opioid; Antineoplastic Combined Chemothera | 2007 |
Intra-arterial BCNU therapy in the treatment of metastatic brain tumor from lung carcinoma: a preliminary report.
Topics: Adult; Aged; Brain Neoplasms; Carmustine; Carotid Arteries; Female; Humans; Infusions, Intra-Arteria | 1979 |
Use of recombinant human hematopoietic growth factors and autologous bone marrow transplantation to attenuate the neutropenic trough of high-dose therapy.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Specimen Co | 1990 |
Pain associated with peripheral infusion of carmustine.
Topics: Carmustine; Catheterization, Peripheral; Humans; Infusions, Intravenous; Lidocaine; Pain | 1991 |
M-2 protocol for melphalan-resistant and relapsing multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Marrow; Carmustine | 1988 |
Phase I trial of thermochemotherapy for brain malignancy.
Topics: Adult; Body Temperature; Brain Neoplasms; Carmustine; Combined Modality Therapy; Drug Evaluation; Fe | 1985 |